Connect with us

Hi, what are you looking for?

Wednesday, May 31, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Shoppers Drug Mart hands its medical cannabis business over to Avicanna

Avicanna will be introducing a new medical cannabis care platform website focusing on patient education

Shoppers Drug Mart hands its medical cannabis business over to Avicanna
Photo via Avicanna

Shoppers drug mart has revealed that it plans to phase out its medical cannabis business over the next three months and hand it over to Toronto’s Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN).

The pharmacy chain owned by Loblaw Companies Limited (TSX: L) announced the development on Tuesday and plans to continue supporting patients while its assets and services are being transferred over to Avicanna in the coming weeks.

As part of the transition, Avicanna will be introducing the new medical cannabis care site Registration for the new platform will be opening this May and the site will have a series of patient support programs led by pharmacists.

Read more: Entourage Health launches new CBD-infused gum

Read more: High Tide reports second consecutive quarter record revenue in Q1 2023

Medical Cannabis by Shoppers has been providing patients with merchandise from major brands such as Broken Coast, Tilray Brands Inc.’s (NASDAQ: TLRY) (TSX: TLRY) Aphria and The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) (OTC: TGODF) for the past four years.

Patients will be able to access a similar product portfolio through along with an array of training and patient education programs and specific services for specialized groups like Veterans.

“As we move away from medical cannabis distribution, we remain firm in our belief that this medication should be dispensed in pharmacies like all others and will continue our advocacy to that end,” said Jeff Leger, President of Shoppers Drug Mart.

“We are motivated towards furthering the work started by Shoppers to create Canada’s leading independent, comprehensive medical cannabis platform and continuing our efforts towards advancing access to medical cannabis and its long-term incorporation into the standard of care,” added Aras Azadian, CEO of Avicanna.

Read more: Inaccurate THC levels in Canadian cannabis sparks concerns across industry

Read more: SciSparc conducts CBD oil clinical trial for children with autism

In January and February this year, Avicanna’s Colombian subsidiary Santa Marta Golden Hemp S.A.S. completed its first shipment of feminized cannabis seeds to Spain and the company expanded its partnership with Viola Brands from Canada into the United Kingdom.

Loblaw’s completed its acquisition of Shoppers Drug Mart for $12.4 billion in 2014, acquiring approximately 1,200 locations at the time.

Avicanna’s stock shot up by 18.42 per cent on Tuesday to $0.45 and Loblaw’s stock rose by 1.19 per cent to $120.13 on the Toronto Stock Exchange.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Rowan Dunne on Twitter










Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


The THCV vape and gummies will be launched by Organigram this summer or fall


The company acquired a patent for its Invisicare skin delivery system last September


The company aims to start selling TGOD products starting in in Q4 this year


The company increased its revenue by 14 per cent YoY to US$336.5 million